Red light therapy has become the wellness world’s golden child. Devices ranging from $30 face panels to $10,000 full-body setups are flooding the market, and the marketing is almost uniformly breathless - wrinkles, inflammation, mitochondria, performance, recovery. When side effects get mentioned at all, they’re typically dismissed in a single sentence.
“Some people experience temporary eye strain or mild skin redness.”
That’s not wrong. It’s just profoundly incomplete.
What the peer-reviewed literature actually shows is that red light therapy operates on a hormetic dose-response curve with real biphasic behavior. It interacts meaningfully with your circadian biology, cancer biology, thyroid physiology, and photosensitizing medications - and right now, millions of people are using it without any meaningful protocol awareness.
This isn’t a hit piece on red light therapy. The benefits are legitimate and well-documented. But the side effect profile deserves a serious, adult conversation - one that treats you like someone capable of understanding nuance rather than a consumer who just needs reassurance.
Why the Side Effect Picture Is So Murky
Before getting into the specific risks, it’s worth understanding why this information is so poorly communicated in the first place. Three structural problems distort the entire landscape.
The dose problem is arguably the most fundamental. Unlike pharmaceuticals, there is no standardized dose of red light therapy enforced across commercial devices. Power density, wavelength, treatment duration, distance from the device, pulse frequency, and target tissue all interact to create wildly different biological outcomes. A study showing benefits at 4 J/cm² tells you nothing about what happens at 80 J/cm² - which some home users are routinely achieving without realizing it.
The Arndt-Schulz problem compounds this further. Photobiomodulation research has repeatedly demonstrated a biphasic dose response: low doses stimulate, high doses inhibit. The same wavelength that promotes cellular proliferation at one fluence can suppress it - or cause outright cytotoxicity - at another. More is not better. In some cases, more is actively harmful.
The publication bias problem rounds out the picture. Industry-funded research on commercially sold devices has an obvious incentive structure, and studies showing harm get published far less frequently than studies showing benefit. This isn’t conspiracy - it’s standard publication bias - but it systematically skews the available literature toward optimism.
Understanding these three problems reframes every “rare side effect” claim you’ll encounter in product marketing and influencer content.
You Can Actually Overdose Your Mitochondria
This is the finding that genuinely surprises most experienced biohackers, and it’s arguably the most important thing to understand about red light therapy.
The mechanism behind RLT’s primary benefit is well-established. Photons at red and near-infrared wavelengths are absorbed by cytochrome c oxidase (COX), the terminal enzyme in the mitochondrial electron transport chain. This absorption dissociates inhibitory nitric oxide from COX, upregulates ATP production, reduces reactive oxygen species in a dose-dependent manner, and triggers downstream signaling cascades involving AMPK, mTOR, and Nrf2.
Here’s what that same literature shows happens when you push the dose too far.
At excessive fluence levels, ROS production increases rather than decreases, mitochondrial membrane permeability transition gets triggered, and apoptotic signaling pathways activate in exposed cells. COX becomes inhibited rather than stimulated - the precise opposite of the intended effect. A 2017 review in Photomedicine and Laser Surgery documented that optimal fluence for most tissue types falls between 1-10 J/cm², with inhibitory effects appearing above 10-30 J/cm² depending on tissue type and wavelength.
What Overdosing Actually Feels Like
The practical implication here is significant. Someone using a high-powered panel at 100 mW/cm² for 20 minutes at close range is delivering approximately 120 J/cm² - potentially 10 to 100 times the optimal therapeutic dose. They are not getting more benefit. They are generating net mitochondrial stress.
The symptom profile of overdosing looks like this:
- Fatigue after sessions rather than increased energy
- Increased inflammation markers rather than decreased ones
- Skin hyperpigmentation rather than improvement
- Paradoxical worsening of the condition being treated
Most users interpret these as detox reactions or healing crises. Some of them genuinely are. Others are straightforward overdose effects from treating dose as if it’s irrelevant.
What to do about it: Calculate your joules per centimeter squared before your next session. Power density in mW/cm² multiplied by time in seconds, then divided by 1,000, gives you J/cm². For most applications, target 3-10 J/cm² at the tissue level - not at the device surface. And factor in the inverse square law: doubling your distance from the device reduces intensity by approximately 75%.
Red Light Is Not Circadian-Neutral
This is the angle that almost no one in the biohacking space is discussing seriously, and the implications deserve far more attention than they’re currently getting.
Red light therapy is broadly promoted as circadian-friendly. The reasoning goes that red wavelengths don’t suppress melatonin the way blue light does, making evening RLT sessions safe or even beneficial for recovery. This logic is partially correct - and partially dangerous oversimplification.
While red light doesn’t activate melanopsin-containing retinal ganglion cells as powerfully as blue light, it is not circadian-neutral. Research has shown that red wavelengths still register through classical rod and cone pathways that feed directly into the suprachiasmatic nucleus. The effect is smaller than blue light. It is not zero.
The Core Temperature Mechanism Nobody Mentions
The more underappreciated mechanism involves core body temperature. RLT increases mitochondrial heat production and local tissue temperature. Applying full-body red light therapy in the evening raises core body temperature at precisely the time when your thermoregulatory system is supposed to initiate the 0.5-1°C drop that signals sleep onset to the brain. This thermogenic effect can meaningfully delay sleep onset - not through melatonin suppression, but through an entirely different pathway most users never consider.
There’s a third layer. A 2019 study in PLOS ONE documented that 670nm red light altered the expression of BMAL1 and PER2 - core components of the molecular circadian clock - in retinal tissue.
Evening full-body RLT sessions may be subtly degrading your sleep architecture in ways that don’t show up as obvious insomnia, but manifest as reduced slow-wave sleep, lower HRV, and persistent next-day recovery deficits.
If you’re tracking with an Oura Ring, WHOOP, or Garmin device, this is worth running as a controlled self-experiment. Four weeks of morning RLT only, four weeks of evening RLT only, same duration and dose, and compare your readiness scores across both periods. The data might genuinely surprise you.
What to do about it: Default to morning or early afternoon sessions for systemic applications. If evening use is unavoidable, skip full-body sessions within two hours of bed. For late-day sessions, prioritize 810-850nm near-infrared over 630-660nm red, since NIR has somewhat less visual system interaction at equivalent doses.
The Cancer Question Nobody Wants to Answer Honestly
This is where the conversation gets genuinely complicated, and where intellectual honesty matters most. Let’s be precise about what the actual concern is.
The standard industry response to “can red light cause cancer?” is categorical: red light is non-ionizing, it doesn’t damage DNA directly, and it’s completely different from UV light. All of that is technically accurate. It also sidesteps the real concern entirely.
The legitimate concern isn’t carcinogenesis. It’s cancer promotion.
Photobiomodulation, by design, stimulates cellular proliferation and inhibits apoptosis. That’s exactly why it works for wound healing, muscle recovery, and skin rejuvenation. But the same pathways that accelerate healing in normal cells - mTOR activation, increased ATP production, reduced oxidative stress signaling that normally triggers cell death - could theoretically accelerate proliferation in pre-cancerous or cancerous cells.
A 2012 study in Lasers in Surgery and Medicine demonstrated that low-level laser therapy accelerated the growth of breast cancer cells in vitro. A 2020 review in Photobiomodulation, Photomedicine, and Laser Surgery explicitly flagged the concern for melanoma and noted that while population-level epidemiological evidence doesn’t yet show elevated cancer rates in RLT users, the mechanistic concern remains biologically plausible and significantly understudied.
Specific Areas of Concern
The skin oncology community has flagged concern about applying RLT over skin lesions of unclear origin. Red and NIR light penetrates the dermis and hypodermis substantially. If a melanoma is developing, delivering pro-proliferative signaling to the surrounding tissue is a concern that deserves serious attention - not dismissal.
The thyroid presents a related issue. Thyroid nodules are present in approximately 19-68% of the general population by ultrasound. The majority of people who have them don’t know it. Someone applying RLT to the throat region without knowing their thyroid status is delivering pro-proliferative signaling to tissue they haven’t characterized.
The oncology community’s consensus on active cancers is unambiguous: do not apply RLT over known or suspected cancer sites. This guidance is routinely violated by wellness consumers who don’t know they have a precancerous lesion, or who are in early remission without recent clean imaging.
What to do about it: Get an annual full-body skin check from a dermatologist. Know your thyroid status - TSH, free T3, free T4, and ultrasound if you have nodules or relevant family history. Avoid applying RLT over any unexplained or changing skin lesion, and consult a dermatologist before beginning RLT if you have a personal or family history of melanoma.
The Pharmaceutical Minefield
This one should appear in every single piece of content about red light therapy. It almost never does.
A significant number of common medications and supplements dramatically increase photosensitivity - including to red and near-infrared wavelengths. Users on these agents may experience accelerated photoaging, inflammatory skin reactions, and phototoxic responses at doses that other people tolerate without any issue at all.
Common Photosensitizing Agents
| Category | Examples | Notes |
|---|---|---|
| Tetracycline antibiotics | Doxycycline | Widely used for acne, Lyme, rosacea |
| Fluoroquinolones | Ciprofloxacin, levofloxacin | Common broad-spectrum antibiotics |
| Thiazide diuretics | Hydrochlorothiazide | One of the most prescribed drugs in the US |
| NSAIDs | Ibuprofen, naproxen | Risk increases with chronic use |
| Cardiac medications | Amiodarone | Potent and long-lasting sensitization |
| Topical retinoids | Tretinoin, isotretinoin | Frequently combined with RLT for skin |
| Supplements | St. John’s Wort | Often overlooked as a sensitizer |
The retinoid combination deserves specific attention because it’s actively promoted in anti-aging communities. Combining tretinoin with red light therapy for skin rejuvenation is extremely common practice. Tretinoin substantially increases photosensitivity, and the combination can produce skin reactions that initially look like results - increased redness, surface inflammation - and get interpreted as progress rather than as a phototoxic response that’s actively degrading the skin barrier.
What to do about it: Cross-reference your full medication and supplement stack against photosensitivity databases before starting an RLT protocol. The FDA MedWatch database and Micromedex are reliable starting points. If you’re currently on doxycycline for any indication, reconsider aggressive RLT sessions until you’re off it. If you’re using topical retinoids, don’t apply them immediately before a face panel session.
Thyroid Overstimulation Is a Real Risk
The RLT-thyroid story is genuinely complex, and the complexity gets underreported in both directions - which is part of what makes it so easy to get wrong.
Multiple controlled trials have documented that red light therapy applied to the thyroid region reduces thyroid peroxidase antibodies, improves thyroid ultrasound appearance, reduces levothyroxine dosage requirements, and improves quality of life in Hashimoto’s patients. A landmark 2013 randomized controlled trial by Höfling et al. in Lasers in Surgery and Medicine showed statistically significant benefits that have since been replicated by independent groups.
This has led to widespread adoption of throat-area RLT protocols in the autoimmune and thyroid biohacking communities. For people with confirmed hypothyroidism and Hashimoto’s, the evidence is genuinely encouraging.
Here’s the part that consistently gets glossed over.
For people with subclinical hyperthyroidism, Graves’ disease, nodular goiter, or any condition where thyroid output is already running at the upper end of normal range, that same stimulation can push them into symptomatic hyperthyroidism - palpitations, anxiety, heat intolerance, weight loss, and insomnia. In susceptible individuals, atrial fibrillation becomes a real concern.
If you’re applying RLT to your throat without knowing your thyroid status, you are modulating a hormone axis completely blind. That is not a reasonable trade-off regardless of how compelling the anecdotal evidence looks in online communities.
What to do about it: Before applying RLT to the thyroid region, establish your baseline - TSH, free T3, free T4, and antibody status at minimum. If you’re on levothyroxine and start a thyroid RLT protocol, recheck your labs at four to eight weeks. If you have Graves’ disease or any form of hyperthyroidism, avoid direct thyroid RLT entirely.
Eye Safety Goes Deeper Than “Wear Goggles”
Eye safety gets more attention than any other RLT side effect - and even here the conversation tends to stay at surface level.
The standard advice is to wear protective goggles rated for the specific wavelengths you’re using. That advice is correct. But there are meaningful layers beneath it.
Near-infrared light is being actively researched as a clinical treatment for age-related macular degeneration, glaucoma, retinitis pigmentosa, and diabetic retinopathy. Multiple trials have shown genuine benefit from low-level NIR exposure to retinal tissue. This has led some users to deliberately remove their goggles during NIR sessions, believing they’re self-administering a therapeutic ocular treatment.
Here’s why that reasoning is genuinely dangerous without expert oversight.
The therapeutic window for ocular NIR appears extremely narrow. More critically, the eye lacks pain receptors sensitive to NIR radiation. UV damage causes immediate, obvious pain. NIR retinal damage can accumulate silently over months before manifesting as vision changes. Additionally, research suggests potential for NIR-induced posterior subcapsular cataracts with chronic high-dose exposure - a permanently disabling outcome in a way that most other RLT side effects are simply not.
What to do about it: Wear goggles, and confirm they are rated for your specific wavelengths - not just UV. Cheap safety glasses that are only UV-rated offer zero protection from visible red and near-infrared light. If you have a diagnosed retinal condition and want to explore NIR therapy, that conversation belongs in an ophthalmologist’s office, not in a home biohacking protocol.
A Practical Framework for Responsible Use
Given everything above, here’s how to approach red light therapy with actual protocol intelligence rather than wishful thinking.
Before You Start
- Calculate your device’s actual power density in mW/cm² and verify it where possible - many devices are significantly over or understated by manufacturers
- Determine your target fluence of 3-10 J/cm² for most applications and calculate the time needed at your working distance to hit that range
- Get baseline labs including a thyroid panel, CBC, and relevant inflammatory markers
- Cross-reference your full medication and supplement stack for photosensitizers
- Schedule a skin check if you haven’t had one in the past year
- Confirm your eye protection is rated for the specific wavelengths your device emits
During Your Protocol
- Prefer morning sessions for systemic full-body applications
- Start at the lower end of the dose range and assess your response over two to three weeks before increasing
- Track objective biomarkers - HRV, sleep staging, and inflammatory markers tell you things your subjective perception consistently misses
- Watch for warning signs: post-session fatigue, paradoxical condition worsening, unexplained skin changes, or palpitations during throat protocols
Higher-Risk Situations
| Situation | Recommended Approach |
|---|---|
| Active cancer or recent remission | Consult oncologist before any RLT protocol |
| Thyroid disease | Monitor labs, work with a physician |
| Photosensitizing medications | Reduce session intensity and duration meaningfully |
| Undiagnosed skin lesions | Dermatologist evaluation before starting |
| Pregnancy | Avoid - insufficient safety data exists |
The Bottom Line
Red light therapy is one of the most evidence-supported tools in a serious optimization stack. The benefits are real, the research is real, and for most healthy people using reasonable protocols, the side effect profile genuinely is mild.
But that sentence is doing a lot of work.
The person running a high-powered panel at close range twice daily has overdosed their mitochondria. The person applying RLT to their throat while in subclinical hyperthyroidism is modulating their endocrine system blind. The person on doxycycline doing 20-minute face sessions has created a photosensitization experiment they never meant to run. The person whose Oura readiness scores have quietly declined since starting evening full-body sessions has found their answer right here.
The tool is powerful. The dose-response relationship is real. The drug and supplement interactions are real. And the “it’s just light, there are basically no side effects” narrative has served the industry well while consistently underserving the people actually using these devices.
Treat red light therapy like the legitimate physiological intervention it is - with protocol intelligence, baseline awareness, and ongoing objective monitoring - and it earns its place in a serious longevity and performance practice.
Treat it like a passive wellness accessory that requires no thought, and sooner or later, you may collect one of the side effects the marketing material forgot to mention.